Professor, Neurology, University Kansas School of Medicine
Neurology
Dr. Russell H. Swerdlow, MD
|
|
Give Review
Russell Swerdlow practices Neurology. He went to medical school at NYU School of Medicine. Russell H. Swerdlow is a published doctor as well. He has 100 publications published. The latest was: Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Russell Swerdlow accepts Medicare payments and is registered with Medicare.gov.
Publications
- TNFα in Cerebral ischemia: another stroke against you?
- Mitochondrial Lysates Induce Inflammation and Alzheimer's Disease-Relevant Changes in Microglial and Neuronal Cells.
- BDNF, fitness, and the Brain.
- Regulation of Mitochondrial Function and Cellular Energy Metabolism by Protein Kinase C-λ/Ä: A Novel Mode of Balancing Pluripotency.
- Oxaloacetate Activates Brain Mitochondrial Biogenesis, Enhances the Insulin Pathway, Reduces Inflammation, and Stimulates Neurogenesis.
- Effect of high-intensity exercise on aged mouse Brain mitochondria, neurogenesis, and inflammation.
- Altering O-linked β-N-Acetylglucosamine cycling disrupts mitochondrial function.
- Is Alzheimer's Disease a Systemic Disease?
- Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies.
- Bioenergetic medicine.
- High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal Brain aging.
- Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): A paradigm worth exploring.
- Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's Disease cybrid cell.
- The Alzheimer's Disease mitochondrial cascade hypothesis: Progress and perspectives.
- Lactate Administration Reproduces Specific Brain and Liver Exercise-Related Changes.
- Backwaters and rapids on the amyloid river.
- Effect of Cholinergic Signaling on Neuronal Cell Bioenergetics.
- "Untangling" the relationship between Alzheimer Disease and dementia with Lewy bodies.
- Altered neurochemical profile after traumatic Brain injury: (1)H-MRS biomarkers of pathological mechanisms.
- Mitochondrial abnormalities in Alzheimer's Disease: possible targets for therapeutic intervention.
- Maternal Family History is Associated with Alzheimer's Disease Biomarkers.
- Effect of Exercise on Mouse Liver and Brain Bioenergetic Infrastructures.
- Alzheimer Disease: Can the exam predict the pathology?
- Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.
- β-Apptists and Tauists, it is time for a sermon from the book of biogenesis.
- Alzheimer's Disease Pathologic Cascades: Who Comes First, What Drives What.
- Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases.
- Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease.
- Brain aging, Alzheimer's Disease, and mitochondria.
- Reduced Mitochondria Cytochrome Oxidase Activity in Adult Children of Mothers with Alzheimer's Disease.
- Insulin is differentially related to cognitive decline and atrophy in Alzheimer's Disease and aging.
- Cardiorespiratory fitness is associated with atrophy in Alzheimer's and aging over 2 years.
- Ncb5or deficiency increases fatty acid catabolism and oxidative stress.
- Progressive regional atrophy in normal adults with a maternal history of Alzheimer Disease.
- Does Mitochondrial DNA Play a Role in Parkinson's Disease? A Review of Cybrid and other Supportive Evidence.
- Reduced lean mass in early Alzheimer Disease and its association with brain atrophy.
- An Alzheimer Disease presenilin mutation, syndrome diversity, and a shrinking world.
- Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's Disease pathology.
- Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production.
- Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
- The Alzheimer's Disease mitochondrial cascade hypothesis: an update.
- Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet.
- Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's Disease cybrids.
- Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's Disease.
- Calpain-mediated MPP+ Toxicity in mitochondrial DNA depleted cells.
- PET sheds light on Alzheimer's Disease genetic risk.
- Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies.
- Is aging part of Alzheimer's Disease, or is Alzheimer's Disease part of aging?
- Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem.
- The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells.
- Fatal encephalitis in a patient with refractory celiac Disease presenting with myorhythmia and carpal spasm.
- Cell and animal models of mtDNA biology: progress and prospects.
- Short-term effect of Dementia disclosure: how patients and families describe the diagnosis.
- Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria.
- Differential regulation of intracellular calcium oscillations by mitochondria and gap junctions.
- Mitochondria-derived oxidative stress induces a heat shock protein response.
- Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's Disease worsen with passage in culture.
- Dystonia with and without deafness is caused by TIMM8A mutation.
- Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign.
- Mitochondrial DNA--related mitochondrial dysfunction in neurodegenerative Diseases.
- Mitochondria in Alzheimer's Disease.
- Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson''s Disease.
- Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson''s subject mitochondrial transfer.
- Polymorphic variation in cytochrome oxidase subunit genes.
- The Alzheimer''s Disease mitochondrial cascade hypothesis.
- Microtubule depolymerization potentiates alpha-synuclein oligomerization.
- Nerve growth factor attenuates oxidant-induced β-amyloid neurotoxicity in sporadic Alzheimer's Disease cybrids.
- Alternate day fasting impacts the Brain insulin-signaling pathway of young adult male C57BL/6 mice.
- Maternal transmission of Alzheimer''s Disease: prodromal metabolic phenotype and the search for genes.
- Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer''s Disease.
- Brain glucose metabolism in Alzheimer's Disease.
- Continuous culture of neuronal cells from adult human olfactory epithelium.
- Bioenergetic Dysfunction and Inflammation in Alzheimer's Disease: A Possible Connection.
- Reduced gray matter volume in normal adults with a maternal family history of Alzheimer Disease.
- Cardiorespiratory fitness and brain atrophy in early Alzheimer Disease.
- Autosomal dominant subcortical gliosis presenting as frontotemporal Dementia.
- Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP Toxicity by inhibiting nitric oxide synthase.
- Behcet's Disease: presentation with sagittal sinus thrombosis diagnosed noninvasively.
- Origin and functional consequences of the complex I defect in Parkinson's Disease.
- Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's Disease.
- Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's Disease.
- Cybrids in Alzheimer's Disease: a cellular model of the Disease?
- Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson''s Disease.
- Mitochondrial dysfunction in idiopathic Parkinson Disease.
- Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's Disease cybrids.
- Mitochondria in sporadic amyotrophic lateral Sclerosis.
- Is NADH effective in the treatment of Parkinson''s Disease?
- Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's Disease family.
- Information overload? Let a computer give you a hand.
- Risk factors for schizophrenia.
- Characterization of cybrid cell lines containing mtDNA from Huntington's Disease patients.
- Mitochondrial abnormalities in non-alcoholic steatohepatitis.
- Parkinson Disease in twins.
- Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's Disease and Parkinson's Disease.
- Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's Disease cybrid cell lines.
- Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's Disease.
- Alzheimer's Disease cybrids replicate beta-amyloid abnormalities through cell death pathways.
- Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson diseas...
- Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear Palsy.
Schools
New York University
University Of Virginia
Western State Hospital
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Background: yellow;'>Background: yellow;'>Background: yellow;'>Background: yellow;'>Disease
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
NYU School of Medicine
Hospital
-
The University of Kansas Hospital
Drug Facts
| NPI NUMBER | 1942379581 | |
| NPPES Provider LastName | SWERDLOW | |
| NPPES Provider FirstName | RUSSELL | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Neurology | |
| Total Claim Count | 380.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942379581 |
| Last Name Of The Provider | SWERDLOW |
| First Name Of The Provider | RUSSELL |
| View All |
Similar Doctors
|
|
Dr. Michael G. Abraham, MD |
|
|
Dr. Richard M. Dubinsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie D. Glenn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tekalign A. Burka, MD |
|
|
Dr. Cynthia L. Costa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jolene Mitchell, DO |
|
|
Dr. Mariano Porto Jr., MD |
|
|
Dr. Arthur R. Dick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tara A. Quesnell, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Bickel, MD |